Auto-antibodies in hepatitis C.

[1]  M. Beaugrand,et al.  Antimitochondrial antibodies in patients with chronic hepatitis C. , 2008, Liver.

[2]  G. Realdi,et al.  Serum antibodies to thymus epithelial cells in non-A, non-B and cryptogenic chronic liver disease. , 2008, Liver.

[3]  F. Alvarez,et al.  Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. , 1999, Gastroenterology.

[4]  J. Tojo,et al.  Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C. , 1998, Fukushima journal of medical science.

[5]  L. Seeff.  The natural history of hepatitis C—A quandary , 1998, Hepatology.

[6]  L. Musset,et al.  Hepatitis C virus infection and cryoglobulinemia. , 1998, Journal of hepatology.

[7]  M. Houghton,et al.  Binding of hepatitis C virus to CD81. , 1998, Science.

[8]  M. Oldstone.  Molecular mimicry and immune‐mediated diseases , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  T. Berg,et al.  A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. , 1998, Journal of hepatology.

[10]  P. Giordano,et al.  Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia , 1998, British journal of haematology.

[11]  J. Salmerón,et al.  Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. , 1998, Archives of internal medicine.

[12]  V. Leroy,et al.  Prevalence and significance of anticardiolipin, anti‐β2 glycoprotein I and anti‐prothrombin antibodies in chronic hepatitis C , 1998 .

[13]  Iorio,et al.  Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection , 1998 .

[14]  D. Vergani,et al.  A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1. , 1998, Journal of immunological methods.

[15]  I. Mcfarlane,et al.  The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis , 1998, Gut.

[16]  D. Smalley,et al.  Autoantibodies present in chronic hepatitis c and chronic hepatitis B viral infections , 1998, Hepatology.

[17]  J. Izopet,et al.  Association of antiphospholipid syndrome and chronic hepatitis C. , 1998, British journal of rheumatology.

[18]  M. Cuccia,et al.  Haplotype HLA-B8-DR3 Confers Susceptibility to Hepatitis C Virus-Related Mixed Cryoglobulinemia , 1998 .

[19]  T. Dyrberg,et al.  Molecular mimicry between non-self, modified self and self in autoimmunity. , 1998, Seminars in immunology.

[20]  A. Floreani,et al.  Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients. , 1998, Italian journal of gastroenterology and hepatology.

[21]  J. Fielding,et al.  Autoimmune disease is not a feature of hepatitis C infection in Ireland. , 1997, Journal of clinical gastroenterology.

[22]  G. Bianchi,et al.  Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile , 1997, Hepatology.

[23]  M. Omata,et al.  Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. , 1997, Journal of hepatology.

[24]  A. Horsch,et al.  Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy , 1997, Hepatology.

[25]  D. Vergani,et al.  Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection. , 1997, Journal of hepatology.

[26]  A. Weetman,et al.  Failure to find an association between hepatitis C virus and thyroid autoimmunity. , 1997, Thyroid : official journal of the American Thyroid Association.

[27]  V. del Pozo,et al.  Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens. , 1997, Journal of hepatology.

[28]  F. Bianchi,et al.  Anti‐neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis , 1997, Hepatology.

[29]  D. Vergani,et al.  Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. , 1997, Journal of immunology.

[30]  M. Gaffey,et al.  The international autoimmune hepatitis score in chronic hepatitis C , 1997, Journal of viral hepatitis.

[31]  A. Németh,et al.  Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden. Swedish Internal Medicine Liver club. , 1997, Scandinavian journal of gastroenterology.

[32]  R. Mcmurray,et al.  Hepatitis C virus infection and autoimmunity. , 1997, Seminars in arthritis and rheumatism.

[33]  P. Pontisso,et al.  Non-organ specific autoantibodies in children with chronic hepatitis C. , 1996, Journal of hepatology.

[34]  M. Clementi,et al.  Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis. , 1996, Journal of hepatology.

[35]  M. Lenzi,et al.  Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques. , 1995, Journal of immunological methods.

[36]  D. Vergani,et al.  Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. , 1995, Gut.

[37]  M. de Carli,et al.  Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients , 1995, Journal of medical virology.

[38]  K. Reddy,et al.  Absence of anti‐LKM‐1 antibody in hepatitis C viral infection in the United States of America , 1995, Journal of viral hepatitis.

[39]  M. Lenzi,et al.  Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. , 1995, Gut.

[40]  S. Targan,et al.  High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. , 1995, Gastroenterology.

[41]  H. Bonkovsky,et al.  High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C , 1995, Hepatology.

[42]  D. Vergani,et al.  Anti‐liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease , 1995, Hepatology.

[43]  D. Vergani,et al.  Progress in Pediatric Autoimmune Hepatitis , 1994, Seminars in liver disease.

[44]  F. Seibold,et al.  Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. , 1994, Gastroenterology.

[45]  M. Manns,et al.  Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. , 1992, Gastroenterology.

[46]  S. Laperche,et al.  Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis , 1992, Hepatology.

[47]  M. Lenzi,et al.  Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection. , 1992, Gut.

[48]  E. Schrumpf,et al.  Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases. , 1992, Gastroenterology.

[49]  R. Tedder,et al.  Hepatitis C viraemia in adults with type 2 autoimmune hepatitis , 1991, Journal of medical virology.

[50]  M. Lenzi,et al.  Anti‐nuclear antibodies of primary biliary cirrhosis recognize 78–92‐kD and 96–100‐kD proteins of nuclear bodies , 1991, Clinical and experimental immunology.

[51]  M. Lenzi,et al.  Anti-HCV testing in autoimmune hepatitis and primary biliary cirrhosis , 1990, The Lancet.

[52]  M. Lenzi,et al.  Anti-actin antibodies: a new test for an old problem. , 1990, Journal of immunological methods.

[53]  P. Beaune,et al.  Presence of functional cytochrome P‐450 on isolated rat hepatocyte plasma membrane , 1990, Hepatology.

[54]  M. Lenzi,et al.  Type 2 autoimmune hepatitis and hepatitis C virus infection , 1990, The Lancet.

[55]  M. Buti,et al.  HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN , 1989, The Lancet.

[56]  C. Johanet,et al.  Antibody to liver cytosol (anti‐LC1) in patients with autoimmune chronic active hepatitis type 2 , 1988, Hepatology.

[57]  H. Hauri,et al.  Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[58]  O. Bernard,et al.  Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily , 1988, The Journal of experimental medicine.

[59]  F. Alvarez,et al.  Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis , 1987, Hepatology.

[60]  C. Crespi,et al.  Autoantibodies to Thymic Epithelial Cells in δ Infection , 1986 .

[61]  F. Bianchi,et al.  Autoimmunity in chronic liver disease caused by hepatitis delta virus. , 1986, Journal of clinical pathology.

[62]  M. Lenzi,et al.  Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. , 1985, Journal of clinical pathology.

[63]  F. Bianchi,et al.  Close Association Between Basal Cell Layer Antibodies and Hepatitis B Virus‐Associated Chronic Delta Infection , 1984, Hepatology.

[64]  F. Negro,et al.  Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. , 1983, Clinical and experimental immunology.

[65]  I. Mackay,et al.  Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis. , 1982, Clinical and experimental immunology.

[66]  V. Schuermans,et al.  IMPAIRED NEUTROPHIL PHAGOCYTOSIS , 1974 .

[67]  E. Holborow,et al.  Smooth Muscle Autoantibodies in Infectious Mononucleosis , 1973, British medical journal.

[68]  L. Muratori.  In situ reverse transcriptase-polymerase chain reaction: an innovative tool for hepatitis C virus RNA detection and localisation, and for quantification of infected cells. , 1998, European journal of histochemistry : EJH.

[69]  I. Mcfarlane,et al.  Molecular basis of autoimmune hepatitis , 1996 .

[70]  A. Czaja.  Autoimmune hepatitis. Evolving concepts and treatment strategies. , 1995, Digestive diseases and sciences.

[71]  F. Giostra,et al.  Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. , 1994, Journal of hepatology.

[72]  F. Giostra,et al.  LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment. , 1993, Journal of hepatology.

[73]  A. Geubel,et al.  Anti-neutrophil antibodies in chronic hepatitis and the effect of α-interferon therapy , 1993 .

[74]  J. Huraux,et al.  Non-organ specific autoantibodies associated with chronic C virus hepatitis. , 1993, Journal of hepatology.

[75]  P. Beaune,et al.  Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. , 1993, Gastroenterology.

[76]  E. Schrumpf,et al.  An autoantibody profile in primary sclerosing cholangitis. , 1987, Journal of hepatology.

[77]  M. Lenzi,et al.  Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM). , 1984, Clinical and experimental immunology.